• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO MISSION (US) 2.75/18; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO MISSION (US) 2.75/18; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 453945
Medical Device Problem Codes Material Deformation (2976); Migration (4003)
Health Effect - Clinical Code Vascular Dissection (3160)
Date of Event 12/20/2021
Type of Reportable Event Serious Injury
Event or Problem Description
An orsiro mission drug-eluting stent system was selected for treatment of a lesion with 99 percent stenosis degree in the cx.After post-dilatation of the orsiro mission stent with an nc balloon and further preparation of another distal lesion, the balloon got stuck at the distal end of the implanted stent.During withdrawal of the balloon, the previously implanted stent became deformed, migrated and was finally adapted to the vessel wall.Additionally, there was a non-flow-limiting dissection which was treated with a des.Finally, the patient was stable and was discharged home.
 
Additional Manufacturer Narrative
Neither the complaint instrument nor the angiographic material was returned for analysis.Therefore, no technical investigation on the subject could be performed.The product release documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for the reported event.Review of the product release documentation confirmed that the instrument was manufactured according to specifications and passed all in-process and final inspections.Based on the conducted investigations of the device being subject to this complaint, no material or manufacturing related root cause was determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO MISSION (US) 2.75/18
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
Manufacturer Contact
6024 jean road
lake oswego, OR 97035
8772459800
MDR Report Key13236397
Report Number1028232-2022-00151
Device Sequence Number4599009
Product Code NIQ
UDI-Device Identifier07640130456013
UDI-Public07640130456013
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P170030
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Reporter Type Manufacturer
Report Source User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 12/27/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/02/2023
Device Model Number453945
Device Catalogue NumberSEE MODEL NO.
Device Lot Number06214847
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/27/2021
Supplement Date Received by Manufacturer01/26/2022
Initial Report FDA Received Date01/12/2022
Supplement Report FDA Received Date01/27/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured08/02/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age77 YR
Patient SexFemale
-
-